>
>
U.S. Hormone Replacement Therapy Market - By Product (Estrogen, Progesterone, Thyroid, Growth Hormone, Testosterone), Route of Administration (Oral, Parenteral), Disease (Menopause, Growth Hormone Deficiency), Distribution Channel, Forecast 2023-2032
Download Free PDF

U.S. Hormone Replacement Therapy Market
Get a free sample of this reportGet a free sample of this report U.S. Hormone Replacement Therapy Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$2,168 $2,550
15% off
$3,000 $3,750
20% off
$3,535 $5,050
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 12
Tables & Figures: 60
Countries covered: 1
Pages: 91
Download Free PDF
U.S. Hormone Replacement Therapy Market Size
The U.S. Hormone Replacement Therapy Market size in 2022 was evaluated to be USD 6.9 billion and is anticipated to be valued at USD 13.4 billion by 2032. The aging U.S. population, with a significant number of women reaching menopausal stages, is a primary driver of the HRT market. As people age, there is an increased prevalence of hormonal imbalances and associated symptoms, resulting in a heightened demand for hormone replacement therapies.
Furthermore, rising cases of thyroid disorders and other endocrine disorders is aiding the market progress. For instance, as per a study published by NIH, in 2022, prevalence of hypothyroidism (HT) was approximately 4.6% in the U.S. population. Additionally, with a surge in the number of specialized clinics and healthcare providers offering HRT coupled with a paradigm shift towards personalized and preventative healthcare in the market is poised to witness high growth.
COVID-19 Impact
The COVID-19 pandemic had a disruptive impact on the market, particularly by affecting the global supply chain and consequently influencing the distribution of hormone replacement therapy worldwide. Further, the lockdown measures posed difficulties for both patients and healthcare practitioners, thereby impeding the market. According to a study published in April 2022, the COVID-19 crisis had a negative impact on growth hormone treatment compliance, with a considerable impact on other daily life factors such as physical activity, sleep time, leisure screen time, and dietary habits.
U.S. Hormone Replacement Therapy Market Trends
The rising prevalence of hormonal disorders serves as a compelling driver for the increased adoption of hormone replacement therapy (HRT). As societies age and lifestyles evolve, there has been a noticeable uptick in the incidence of hormonal imbalances, particularly among the elderly population.
Technological advancements in drug delivery methods have played a pivotal role in driving the hormone replacement therapy (HRT) industry, leading to improved patient adherence, convenience, and treatment outcomes.
U.S. Hormone Replacement Therapy Market Analysis
Based on product, the market is segmented into estrogen & progesterone replacement therapy, thyroid replacement therapy, growth hormone replacement therapy, parathyroid hormone replacement therapy, and testosterone replacement therapy. The estrogen & progesterone replacement therapy segment accounted for highest market share of 55.3% in 2022 and is expected to reach USD 7.5 billion by 2032.
Based on route of administration, the U.S. hormone replacement therapy market is classified into oral, parenteral, and other routes of administration. In 2022, the oral segment secured the largest market share at 43.5% and is anticipated to exhibit substantial growth from 2023 to 2032.
By disease type, the U.S. hormone replacement therapy market is segmented into menopause, hypothyroidism, growth hormone deficiency, hypoparathyroidism, male hypogonadism, and other disease type. In 2022, the menopause segment accounted for highest market share of 50.5% and is anticipated to witness growth at 7 % during the analysis period.
Based on distribution channel, the U.S. hormone replacement therapy market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the hospital pharmacies segment held highest business share of 57.2%.
U.S. Hormone Replacement Therapy Market Share
The key industry players operating in this market have established themselves through top-notch quality products, advanced technology, and a strong market presence. Novo Nordisk A/S, Pfizer, Inc., and Eli Lilly & Company are prominent leaders in this market. These significant players offer a wide range of solutions for hormonal imbalances and disorders. They are consistently involved in creating new opportunities in the healthcare sector.
Market players operating in the U.S. hormone replacement therapy industry is as mentioned below:
U.S. Hormone Replacement Therapy Industry News:
The U.S. hormone replacement therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product, 2018 – 2032 (USD Million)
By Route of Administration, 2018 – 2032 (USD Million)
By Disease Type, 2018 – 2032 (USD Million)
By Distribution Channel, 2018 – 2032 (USD Million)